Seiji Tanaka

Title: Seiji Tanaka: Innovator in Blood Coagulation Detection

Introduction

Seiji Tanaka is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of blood coagulation processes. His innovative work has led to the development of a unique monoclonal antibody that plays a crucial role in understanding blood coagulation.

Latest Patents

Seiji Tanaka holds a patent for a "Monoclonal antibody specific to anti-human fibrin monomer, process for producing the same, hybridomas, and immunoassay method." This invention provides a monoclonal antibody that enables the detection of a native fibrin monomer, which is produced during the initial stages of blood coagulation. The patent also includes a hybridoma and an immunoassay method that allows for high sensitivity and rapid detection of blood coagulation's initial stage. The antibody is specifically reactive with a native fibrin monomer and soluble fibrin, making it a valuable tool in medical diagnostics.

Career Highlights

Seiji Tanaka is associated with Nissui Pharmaceutical Co., Ltd., where he has been instrumental in advancing research in blood coagulation. His work has not only contributed to scientific knowledge but has also paved the way for improved diagnostic methods in clinical settings. With 1 patent to his name, Tanaka's contributions are recognized within the scientific community.

Collaborations

Throughout his career, Seiji Tanaka has collaborated with notable colleagues, including Akiei Hamano and Mamoru Umeda. These collaborations have further enhanced the research and development of innovative solutions in the field of blood diagnostics.

Conclusion

Seiji Tanaka's innovative work in developing a monoclonal antibody for blood coagulation detection highlights his significant contributions to medical science. His research continues to impact the field positively, providing essential tools for understanding and diagnosing blood-related conditions.